Infectious Disease: Gram-Negative Bacterial Pathogens

Deadline
May 17, 2017
OPPORTUNITY NO.
RFA-AI-16-081
MECHANISM
R01
RESEARCH AREA(S)
SYNOPSIS

Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antimicrobial-Resistant Gram-Negative Bacteria

The purpose of this Funding Opportunity Announcement (FOA) is to support milestone-driven projects focused on developing and utilizing novel predictive assays, models and/or research tools based on penetration and efflux of small molecules to facilitate therapeutic discovery for select Gram-negative bacterial pathogens: carbapenem-resistant Enterobacteriaceae (CRE), MDR Acinetobacter and/or MDR Pseudomonas aeruginosa.  

Deadlines:

  • Pre-Application Submission: Apr. 17, 2017
  • Application Submission: 5:00 PM local time of applicant organization, May 17, 2017
ELIGIBILITY

Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.